Moderna vaccine trial pleases investors, EBITDAC backlash, Huawei sanctions
FT News Briefing
00:00
Initial Promising Results from COVID-19 Vaccine Trial
This chapter explores the encouraging early results of a U.S. COVID-19 vaccine trial, which generated optimism among investors due to the favorable immune responses. It underscores the necessity for caution and the importance of larger, more diverse trials to ensure the vaccine's safety and efficacy, especially for older populations at higher risk.
Play episode from 01:55
Transcript
